Joan Schmidt was Appointed as Executive Vice President and General Counsel at DBV-Technologies

Date of management change: July 24, 2018 

What Happened?

New York, -based DBV-Technologies Appointed Joan Schmidt as Executive Vice President and General Counsel


About the Company

DBV Technologies (DBV) is a clinical-stage biopharmaceutical company focused on discovering safe and effective treatments for patients with food allergies and other unmet medical needs. DBV has developed a proprietary technology platform called Viaskin®, which is based on epicutaneous immunotherapy, or EPIT®, DBV`s method of delivering biologically active compounds to the immune system. This novel mechanism of action accesses the immune system through intact skin without allowing passage of the antigen into the bloodstream. The company is also exploring Viaskin® in other areas of unmet need including vaccines, inflammatory conditions and autoimmune diseases. DBV was founded in 2002 by Dr. Pierre-Henri Benhamou, Chairman and CEO, Dr. Christophe Dupont, Chairman of DBV`s Scientific Advisory Board, and Mr. Bertrand Dupont, Chief Technology Officer.


About the Person

Joan Schmidt is Executive Vice President and General Counsel at DBV Technologies. Previously, Joan held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Haider Aliya, Throm Timothy, Mays Richard, McWhinnie Ryan, Shelger James, Klein Gary, Wylie Todd, Phelps Michael, Rumley Jeffrey, Bushard Diana, Oney Elizabeth

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.